Koichi Miyamura

6.1k total citations
204 papers, 3.7k citations indexed

About

Koichi Miyamura is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Koichi Miyamura has authored 204 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Hematology, 69 papers in Immunology and 49 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Koichi Miyamura's work include Hematopoietic Stem Cell Transplantation (116 papers), Acute Lymphoblastic Leukemia research (48 papers) and Acute Myeloid Leukemia Research (44 papers). Koichi Miyamura is often cited by papers focused on Hematopoietic Stem Cell Transplantation (116 papers), Acute Lymphoblastic Leukemia research (48 papers) and Acute Myeloid Leukemia Research (44 papers). Koichi Miyamura collaborates with scholars based in Japan, United States and Greece. Koichi Miyamura's co-authors include Takahiro Fukuda, Yoshiko Atsuta, Yasuo Morishima, Yoshihisa Kodera, Makoto Onizuka, Ritsuro Suzuki, Takehiko Mori, Y Morishima, Tetsuya Eto and Hisashi Sakamaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Koichi Miyamura

198 papers receiving 3.6k citations

Peers

Koichi Miyamura
Mitchell E. Horwitz United States
Peter Kalhs Austria
Marco Mielcarek United States
David A. Jacobsohn United States
Mitchell E. Horwitz United States
Koichi Miyamura
Citations per year, relative to Koichi Miyamura Koichi Miyamura (= 1×) peers Mitchell E. Horwitz

Countries citing papers authored by Koichi Miyamura

Since Specialization
Citations

This map shows the geographic impact of Koichi Miyamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Miyamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Miyamura more than expected).

Fields of papers citing papers by Koichi Miyamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichi Miyamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Miyamura. The network helps show where Koichi Miyamura may publish in the future.

Co-authorship network of co-authors of Koichi Miyamura

This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Miyamura. A scholar is included among the top collaborators of Koichi Miyamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Miyamura. Koichi Miyamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teshima, Takanori, Yasushi Onishi, Koji Kato, et al.. (2024). Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial. International Journal of Hematology. 120(1). 106–116. 1 indexed citations
2.
Ito, Yuri, Yoshihiro Inamoto, Koichi Miyamura, et al.. (2023). Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades. Transplantation and Cellular Therapy. 29(12). 768.e1–768.e10. 3 indexed citations
3.
Morishita, Takanobu, Rena Matsumoto, Tomoki Naito, et al.. (2021). Pretransplant increasing rate of lactate dehydrogenase as a predictor of transplant outcomes for patients with myeloid hematological malignancies. Bone Marrow Transplantation. 56(7). 1732–1736.
4.
Sato, Takahiko, Tatsunori Goto, Takanobu Morishita, et al.. (2021). Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors. International Journal of Hematology. 114(6). 682–690. 2 indexed citations
5.
Sato, Takahiko, Naomi Kawashima, Masafumi Ito, et al.. (2020). Day 0 bone marrow pathology of allogeneic hematopoietic stem cell transplantation is a novel prognostic factor in myeloid malignancies. PubMed. 3(4). 84–91. 1 indexed citations
6.
Miyao, Kotaro, Seitaro Terakura, Fumihiko Kimura, et al.. (2020). Updated Comparison of 7/8 HLA Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Umbilical Cord Blood Transplantation as Alternative Donors in Adults with Acute Leukemia. Biology of Blood and Marrow Transplantation. 26(11). 2105–2114. 12 indexed citations
7.
Morishita, Takanobu, Motohito Okabe, Yoonha Lee, et al.. (2018). Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage Complications. Biology of Blood and Marrow Transplantation. 24(12). 2509–2516. 13 indexed citations
8.
Kawashima, Naomi, Satoshi Nishiwaki, N Shimizu, et al.. (2018). Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program coordination status. International Journal of Hematology. 107(5). 551–558.
9.
Koyama, Daisuke, Makoto Murata, Ryo Hanajiri, et al.. (2017). High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype. PLoS ONE. 12(9). e0185213–e0185213. 3 indexed citations
10.
Miyamura, Koichi. (2016). Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns. International Journal of Hematology. 103(2). 155–164. 19 indexed citations
11.
Kohgo, Yutaka, Akio Urabe, Yurdanur Kılınç, et al.. (2015). Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias. Acta Haematologica. 134(4). 233–242. 11 indexed citations
12.
Terakura, Seitaro, Yoshiko Atsuta, Nobuhiro Tsukada, et al.. (2015). Comparison of Outcomes of 8/8 and 7/8 Allele–Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia. Biology of Blood and Marrow Transplantation. 22(2). 330–338. 79 indexed citations
13.
Morishima, Yasuo, Koichi Kashiwase, Keitaro Matsuo, et al.. (2014). Biological significance of HLA locus matching in unrelated donor bone marrow transplantation. Blood. 125(7). 1189–1197. 111 indexed citations
14.
Kanda, Yoshinobu, Junya Kanda, Yoshiko Atsuta, et al.. (2014). Changes in the Clinical Impact of High-Risk Human Leukocyte Antigen Allele Mismatch Combinations on the Outcome of Unrelated Bone Marrow Transplantation. Biology of Blood and Marrow Transplantation. 20(4). 526–535. 13 indexed citations
16.
Kuwatsuka, Yachiyo, Akio Kohno, Seitaro Terakura, et al.. (2012). Phase II study of dose‐modified busulfan by real‐time targeting in allogeneic hematopoietic stem cell transplantation for myeloid malignancy. Cancer Science. 103(9). 1688–1694. 8 indexed citations
17.
Shimada, Masako, Makoto Onizuka, Shinichiro Machida, et al.. (2007). Association of autoimmune disease‐related gene polymorphisms with chronic graft‐versus‐host disease. British Journal of Haematology. 139(3). 458–463. 19 indexed citations
18.
Inamoto, Yoshihiro, Koichi Miyamura, Seitaro Terakura, et al.. (2006). Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor. International Journal of Hematology. 83(4). 356–362. 11 indexed citations
19.
Mizuta, Shuichi, Yoshiaki Ito, A Kohno, et al.. (1999). Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Bone Marrow Transplantation. 24(7). 777–784. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026